{
    "id": "correct_subsidiary_00047_3",
    "rank": 38,
    "data": {
        "url": "https://rheosmedical.com/team/",
        "read_more_link": "",
        "language": "en",
        "title": "Rheos Medical",
        "top_image": "https://rheosmedical.com/wp-content/uploads/2023/07/cropped-rheos_medical_logo-favicon-32x32.png",
        "meta_img": "https://rheosmedical.com/wp-content/uploads/2023/07/cropped-rheos_medical_logo-favicon-32x32.png",
        "images": [
            "https://rheosmedical.com/wp-content/uploads/2023/07/rheos_medical_logo_long-scaled.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/07/Bell-1a.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Fuhrman.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/09/adi_raviv.png",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Kanter.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/DuFaux.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Burleson.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Clemow.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Hautamaki.jpg",
            "https://rheosmedical.com/wp-content/uploads/2023/07/e-kaplan2.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Bauer.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/07/Bell-1a.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Fuhrman.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/09/adi_raviv.png",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Kanter.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/DuFaux.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Burleson.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Clemow.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Hautamaki.jpg",
            "https://rheosmedical.com/wp-content/uploads/2023/07/e-kaplan2.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Bauer.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/07/Bell-1a.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/07/Bell-1a.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Fuhrman.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Fuhrman.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/DuFaux.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/DuFaux.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Kanter.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Kanter.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Burleson.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Burleson.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Clemow.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Clemow.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Hautamaki.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Hautamaki.jpg",
            "https://rheosmedical.com/wp-content/uploads/2023/07/e-kaplan2.jpg",
            "https://rheosmedical.com/wp-content/uploads/2023/07/e-kaplan2.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Bauer.jpg",
            "https://rheosmedical.com/wp-content/uploads/2021/05/Bauer.jpg",
            "https://rheosmedical.com/wp-content/uploads/2022/09/adi_raviv.png",
            "https://rheosmedical.com/wp-content/uploads/2022/09/adi_raviv.png",
            "https://rheosmedical.com/wp-content/plugins/gdpr-cookie-compliance/dist/images/gdpr-logo.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://rheosmedical.com/wp-content/uploads/2023/07/cropped-rheos_medical_logo-favicon-32x32.png",
        "meta_site_name": "",
        "canonical_link": "https://rheosmedical.com/team/",
        "text": "Team\n\nManagement & Board of Directors\n\nBrian Bell\n\nFounder & Chief Executive Officer\n\nBrian Bell began his career as a technology and health care analyst for several mutual fund companies, including PIMCO Advisors ($180 billion in assets under management) and most recently with Seed Capital Partners, LLC, an early stage venture fund with backing from Softbank Corporation and JP Morgan Partners.\n\nBradley Fuhrman, MD\n\nFounder & Chief Medical Officer\n\nDr. Fuhrman trained in Pediatrics, Neonatology and Pediatric Cardiology at the University of Minnesota, and went on to be Board Certified in those specialties and in Pediatric Critical Care Medicine. He developed the first Pediatric ICU at University of Minnesota in 1979 and then practiced that subspecialty for over three decades at the University of Minnesota, Children’s Hospital of Pittsburgh, Children’s Hospital of Buffalo and El Paso Children’s.\n\nAdi Raviv\n\nChief Financial Officer\n\nMr. Raviv sits on the board of directors of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) where he chairs the audit and finance committees and is a member of the compensation and strategy committees. He founded HTI Associates LLC in 1996 and since then has served as the managing member of this management consultancy firm that also provides outsourced C-level functions.\n\nJoel Kanter\n\nChairman\n\nMr. Joel Kanter has served as President of Windy City, Inc., a privately held investment firm, since July 1986. From 1989 to November 1999, Mr. Kanter also served as the Chief Executive Officer of Walnut Financial Services, Inc., a publicly traded company (Nasdaq: WNUT).\n\nDoug DuFaux\n\nTechnical Director\n\nMr. DuFaux combines over 20 years of experience in product and process development with extensive experience in manufacturing development, engineering, customer relationships, and intellectual property. His unique combination of industry experience, including medical devices, electronics & controls, advanced materials, consumer products, and chemicals, provides Mr. DuFaux with an effective development perspective.\n\nGene Burleson\n\nDirector\n\nGene has been a First Wave Tech Director since January 2011. He served as Chairman (1989-1997) and CEO and President (1990-1997) of GranCare, Inc., which, under his management, grew from under $10 million in revenue to become one of the nation’s largest publicly traded long-term healthcare providers with revenues in excess of $1 billion.\n\nAlastair Clemow\n\nDirector\n\nDr. Clemow serves as President and Chief Executive Officer of Regentis Biomaterials, a private company developing an innovative material for cartilage repair. Previously he held the position of President and Chief Executive Officer in a number of companies that he helped found including Nexgen Spine.\n\nRaymond Dean Hautamaki, MD\n\nDirector\n\nRaymond Dean Hautamaki MD is board certified internal medicine-pulmonary/ critical care physician practicing in Sarasota, Florida. He attended the University of Florida in Gainesville , Florida for undergraduate studies and medical school.\n\nEric Kaplan\n\nDirector\n\nEric Kaplan is an attorney and tax accountant and since 2003, been a senior financial consultant with Bristol Consultants, LLC and with predecessor companies since 1985. Mr. Kaplan provides consulting services to high-net-worth investors on a variety of matters.\n\nGene Bauer, MD\n\nDirector\n\nEugene Bauer is immediate past co-founder, Chief Medical Officer and member of the board of directors of Dermira, Inc., a biotechnology company recently acquired by Eli Lilly and Company. Prior to founding Dermira, he served as a member of the board of directors of Peplin, Inc., where he also was its President and Chief Medical Officer, until Peplin’s acquisition by LEO Pharma in 2009.\n\nManagement & Board of Directors\n\nBrian Bell\n\nFounder & Chief Executive Officer\n\nBrian Bell began his career as a technology and health care analyst for several mutual fund companies, including PIMCO Advisors ($180 billion in assets under management) and most recently with Seed Capital Partners, LLC, an early stage venture fund with backing from Softbank Corporation and JP Morgan Partners.\n\nBradley Fuhrman, MD\n\nFounder & Chief Medical Officer\n\nDr. Fuhrman trained in Pediatrics, Neonatology and Pediatric Cardiology at the University of Minnesota, and went on to be Board Certified in those specialties and in Pediatric Critical Care Medicine. He developed the first Pediatric ICU at University of Minnesota in 1979 and then practiced that subspecialty for over three decades at the University of Minnesota, Children’s Hospital of Pittsburgh, Children’s Hospital of Buffalo and El Paso Children’s.\n\nAdi Raviv\n\nChief Financial Officer\n\nMr. Raviv sits on the board of directors of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) where he chairs the audit and finance committees and is a member of the compensation and strategy committees. He founded HTI Associates LLC in 1996 and since then has served as the managing member of this management consultancy firm that also provides outsourced C-level functions.\n\nJoel Kanter\n\nChairman\n\nMr. Joel Kanter has served as President of Windy City, Inc., a privately held investment firm, since July 1986. From 1989 to November 1999, Mr. Kanter also served as the Chief Executive Officer of Walnut Financial Services, Inc., a publicly traded company (Nasdaq: WNUT).\n\nDoug DuFaux\n\nTechnical Director\n\nMr. DuFaux combines over 20 years of experience in product and process development with extensive experience in manufacturing development, engineering, customer relationships, and intellectual property. His unique combination of industry experience, including medical devices, electronics & controls, advanced materials, consumer products, and chemicals, provides Mr. DuFaux with an effective development perspective.\n\nGene Burleson\n\nDirector\n\nGene has been a First Wave Tech Director since January 2011. He served as Chairman (1989-1997) and CEO and President (1990-1997) of GranCare, Inc., which, under his management, grew from under $10 million in revenue to become one of the nation’s largest publicly traded long-term healthcare providers with revenues in excess of $1 billion.\n\nAlastair Clemow\n\nDirector\n\nDr. Clemow serves as President and Chief Executive Officer of Regentis Biomaterials, a private company developing an innovative material for cartilage repair. Previously he held the position of President and Chief Executive Officer in a number of companies that he helped found including Nexgen Spine.\n\nRaymond Dean Hautamaki, MD\n\nDirector\n\nRaymond Dean Hautamaki MD is board certified internal medicine-pulmonary/ critical care physician practicing in Sarasota, Florida. He attended the University of Florida in Gainesville , Florida for undergraduate studies and medical school.\n\nEric Kaplan\n\nDirector\n\nEric Kaplan is an attorney and tax accountant and since 2003, been a senior financial consultant with Bristol Consultants, LLC and with predecessor companies since 1985. Mr. Kaplan provides consulting services to high-net-worth investors on a variety of matters.\n\nGene Bauer, MD\n\nDirector\n\nEugene Bauer is immediate past co-founder, Chief Medical Officer and member of the board of directors of Dermira, Inc., a biotechnology company recently acquired by Eli Lilly and Company. Prior to founding Dermira, he served as a member of the board of directors of Peplin, Inc., where he also was its President and Chief Medical Officer, until Peplin’s acquisition by LEO Pharma in 2009."
    }
}